Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《国际感染杂志(电子版)(英文版)》 2012-01
Add to Favorite Get Latest Update

Prevention of Hepatocellular Carcinoma

Ryota Masuzaki;Masao Omata;Department of Surgery,Division of Liver Transplantation Vanderbilt University;Department of Gastroenterology,Yamanashi Central and Kita Hospitals,University of Tokyo;  
Hepatocellular carcinoma(HCC) is the fifth common cancer in the world,showing the third highest cancer related mortality.The prognosis of HCC patients depends not only on tumor stage but also on the background liver function reservoir.Effective treatments for HCC include percutaneous ablation,surgical resection and liver transplantation.Although short-term prognosis of HCC patients has been much improved recently due to advances in early diagnosis and treatment,long-term prognosis is as yet far from satisfactory as indicated by the overall survival at 10 years after apparently curative treatment of only 22%-35%.Primary prevention aims to evade the tumor development with health measures that prevent people from exposure to known risk factors like hepatitis viruses or alcohol,or attenuating liver disease progression to HCC.While secondary prevention aims to diagnose HCC at an early,potentially curable stage,tertiary prevention aims to reduce the risk of HCC recurrence after curative treatment.In this article we focus on prevention of HCC and the new advance in this field.
【CateGory Index】: R735.7
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
Chinese Journal Full-text Database 10 Hits
1 ZHANG Ling-xia,WANG Yong-yi,WANG Shu,LI Jun,MENG Li-shan,XU Mo-yan Expert Panel,302 Hospital of PLA,Beijing 100039,China;Focus on current infectious diseases[J];Infectious Disease Information;2012-01
2 Wan-Yee Lau and Eric C. H. Lai Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China;Hepatocellular carcinoma: current management and recent advances[J];国际肝胆胰疾病杂志(英文版);2008-03
3 HUANG Yong-yue;JIN Jun;TANG Xiao-li;WANG Xiao-yi;Department of Radiology, Shenzhen Shekou People's Hospital of Guangdong Province;Department of Radiology, Xiangya Hospital, Central South University;;Comparative study of DWI and Fi-broscan in diagnosis of liver fibrosis[J];Chinese Journal of Magnetic Resonance Imaging;2013-04
4 LI Bao-liang;MU Yi;JIANG Li;ZHANG Ke;JIA Zhe;HUANG Rong-hai;LU Yan;HE Rong;DING Zhen-hao;LI Qin-tao;GUO Li-min;Department of Hepatobiliary Surgery, Beijing Ditan Hospital, Capital Medical University;;Evaluation on hepatic reserve function of patients with hepatocellular carcinoma after partial hepatectomy by Child-Pugh classification with Fibroscan and ICG measurement[J];Chinese Journal of Liver Diseases(Electronic Version);2013-03
5 Qiao Bin;Wang Ming;Yuan Leyong;Li Yan;People′s Hospital of Wuhan University/Hubei Provincial People′s Hospital;;A study on relationship between genotyping of hepatitis C virus and therapeutic effects[J];International Journal of Laboratory Medicine;2013-21
6 Xin Chen;Hai-Bing Zhang;Zhong-Qi Li;Xiong-Fei Yu;Mei-Fang Yang;Hao-Hao Wang;Li-Song Teng;Department of Oncology First Affiliated Hospital,Zhejiang University School of Medicine;State Key Laboratory for Diagnosis and Treatment of Infectious Diseases First Affiliated Hospital,Zhejiang University School of Medicine;;Indocyanine green clearance in evaluating the recovery of liver reserve function after superselective transarterial chemoembolization[J];国际肝胆胰疾病杂志(英文版);2013-06
7 YAN Zhao-wei,DONG Qiong-zhu.Institutes of Biomedical Sciences,Fudan University,Shanghai(200032),China;ZHU Hai-tao,ZHOU Chuang,ZHANG Xiao-fei,REN Ning,YE Qing-hai,QIN Lun-xiu.Liver Cancer Institute,Zhongshan Hospital,Fudan University,Shanghai(200032),China;Expression and significance of microRNA biosynthesis related genes in hepatocellular carcinoma[J];International Journal of Digestive Diseases;2013-03
8 Roberto Catanzaro;Michele Milazzo;Silvia Arona;Chiara Sapienza;Dario Vasta;Domenico Arcoria;Francesco Marotta;Department of Medical and Pediatric Sciences,Institute of Internal Medicine "A. Francaviglia",Section of Gastro-enterology,University of Catania,"G. Rodolico" Hospital;Laboratory analysis "MedLab-Analisi Cliniche";Specialist in diabetes and metabolic diseases;ReGenera Research Group for Aging Intervention;;Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C[J];国际肝胆胰疾病杂志(英文版);2013-05
9 DUAN Jian-wen;WU Xiao;YE Hai-lin;De-partment of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical College;;The effect and the possible mechanism of 5-Aza-CdR on proliferation and invasiveness of human hepatocellular carcinoma cell strain SMMC-7721[J];Journal of Hepatopancreatobiliary Surgery;2013-05
10 WU Gui-ping;YAN Xue-bing;WANG Xing-tian;HAO Jun-gui;SHEN Pei-pu;LIU Hong;Department of Infectious Diseases, The First Affiliated Hospital of Xuzhou Medical College;Department of Ultrsound, The First Affiliated Hospital of Xuzhou Medical College;Department of Pathology, The First Affiliated Hospital of Xuzhou Medical College;;Preliminary study on non-invasive evaluation of liver fibrosis stage in chronic liver disease by virtual tough tissues quantification technology[J];Chinese Journal of Liver Diseases(Electronic Version);2013-04
China Proceedings of conference Full-text Database 2 Hits
1 YAO Quan-Jun,HU Hong-Tao,LI Hai-Liang,GUO Chen-Yang,MENG Yan-Li,LI Ya-Nan Department of Radiology,Henan Cancer Hospital/The Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou,450008.Address correspondence to LI Hai-Liang;The Clinical Value of Xper CT Image in Diagnose and Treatment for Hypovascular Primary Hepatic Carcinoma[A];[C];2013
2 Wenshuang Wu~(1+),Haoyu Ye~(1,2+),Li Wan~3,Xiaolei Han~1,Guangcheng Wang~1,Jia Hu~1,Minhai Tang~1,Xingmei Duan~1,Yi Fan~1,Shichao He~1,Li Huang~1,Heying Pei~1,Xuewei Wang~1,Xiuxia Li~1,Caifeng Xie~1,Ronghong Zhang~1,Zhu Yuan~1,Yongqiu Mao~1,Yuquan Wei~1,Lijuan Chen~(1*) (1 State Key Laboratory of Biotherapy,West China Hospital,West China Medical School Sichuan University,Keyuan Road 4,Gaopeng Street,Chengdu 610041,China 2 Guangdong Zhongsheng Pharmacy Co.Ltd.,Dongguan 523325,China 3 State Key Laboratory Breeding Base of Systematic Research,Development and Utilization of Chinese Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 610072, China);Millepachine(MIL),a novel chalcone,induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo[A];[C];2013
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved